Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock - $0.001 par value
-
Shares outstanding
-
10,630,964
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
632,473
-
Shares change
-
-10,698
-
Total reported value, excl. options
-
$968,000
-
Value change
-
-$108,653
-
Number of buys
-
9
-
Number of sells
-
6
-
Price
-
$1.53
Institutional Holders of NEPHROS INC - Common Stock - $0.001 par value (NEPH) as of Q2 2022
As of 30 Jun 2022 NEPHROS INC - Common Stock - $0.001 par value (NEPH) had 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 632,473 shares of stock of the company.
Largest 10 holders included BARD ASSOCIATES INC, VANGUARD GROUP INC, HighTower Advisors, LLC, Cowen Prime Advisors LLC, BLAIR WILLIAM & CO/IL, ELKHORN PARTNERS LIMITED PARTNERSHIP, MORGAN STANLEY, STATE STREET CORP, CITADEL ADVISORS LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 15 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.